Sara Bergström Lind

Dr. Sara Bergström Lind

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
JCJonathan Cedernaes
Jonathan Cedernaes
MSMilena Schönke
Milena Schönke
JWJakub Westholm
Jakub Westholm
JMJia Mi
Jia Mi
ACAlexander Chibalin
Alexander Chibalin
Christian BenedictChristian Benedict
Christian Benedict
Simulated shift work uncovers potential tissue mechanisms for metabolic effects attributed to sleep loss and circadian disruption.

18 September 2018 in The Analyst
Verified
Journal Article
Open access
PDF file
MKMalin Källsten
Malin Källsten
RHRafael Hartmann
Rafael Hartmann
KAKonstantin Artemenko
Konstantin Artemenko
SLSara Bergström Lind
Sara Bergström Lind
FLFredrik Lehmann
Fredrik Lehmann
JBJonas Bergquist
Jonas Bergquist
Four different cysteine linked antibody-drug conjugates (ADCs) consisting of Trastuzumab-vc-MMAE were analysed with four common analytical techniques with respect to drug-to-antibody ratio (DAR) and molecular weight.

25 November 2020 in Journal of Virology
Verified
Journal Article
Open access
PDF file
AJAmanda Westergren Jakobsson
Amanda Westergren Jakobsson
BSBo Segerman
Bo Segerman
OWOla Wallerman
Ola Wallerman
SLSara Bergström Lind
Sara Bergström Lind
HZHongxing Zhao
Hongxing Zhao
GAGoran Akusjarvi
Goran Akusjarvi
Work in the adenovirus system led to the groundbreaking discovery of RNA splicing and alternative RNA splicing in 1977. These mechanisms are essential in mammalian evolution, as they increase the coding capacity of a genome.

1 September 2020 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
AKAvinash Khandagale
Avinash Khandagale
MÅMikael Åberg
Mikael Åberg
GWGerhard Wikström
Gerhard Wikström
SLSara Bergström Lind
Sara Bergström Lind
GSGanna Shevchenko
Ganna Shevchenko
CCChristina Christersson
Christina Christersson
Objective: Extracellular vesicles (EVs) have the potential to act as intercellular communicators. The aims were to characterize circulating EVs in patients with pulmonary arterial hypertension (PAH) and to explore whether these EVs contribute to endothelial activation and angiogenesis. Approach and Results: Patients with PAH (n=70) and healthy controls (HC; n=20) were included in this cross-sectional study. EVs were characterized and human pulmonary endothelial cells (hPAECs) were incubated with purified EVs. Endothelial cell activity and proangiogenic markers were analyzed. Tube formation analysis was performed for hPAECs, and the involvement of PSGL-1 (P-selectin glycoprotein ligand 1) was evaluated. The numbers of CD62P + , CD144 + , and CD235a EVs were higher in blood from PAH compared with HC. Thirteen proteins were differently expressed in PAH and HC EVs, where complement fragment C1q was the most significantly elevated protein ( P =0.0009) in PAH EVs. Upon EVs-internalization in hPAECs, more PAH compared with HC EVs evaded lysosomes ( P <0.01). As oppose to HC, PAH EVs stimulated hPAEC activation and induced transcription and translation of VEGF-A (vascular endothelial growth factor A; P <0.05) and FGF (fibroblast growth factor; P <0.005) which were released in the cell supernatant. These proangiogenic proteins were higher in patient with PAH plasma compered with HC. PAH EVs induced a complex network of angiotubes in vitro, which was abolished by inhibitory PSGL-1antibody. Anti-PSGL-1 also inhibited EV-induced endothelial cell activation and PAH EV dependent increase of VEGF-A. Conclusions: Patients with PAH have higher levels of EVs harboring increased amounts of angiogenic proteins, which induce activation of hPAECs and in vitro angiogenesis. These effects were partly because of platelet-derived EVs evasion of lysosomes upon internalization within hPAEC and through possible involvement of P-selectin-PSGL-1 pathway.

1 August 2016 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
BHB. Hernroth
B. Hernroth
SBS. Baden
S. Baden
HTH. Tassidis
H. Tassidis
KHK. Hörnaeus
K. Hörnaeus
JGJ. Guillemant
J. Guillemant
JBJonas Bergquist
Jonas Bergquist

1 December 2013 in Virology
Verified
Journal Article
Closed access
SLSara Bergström Lind
Sara Bergström Lind
KAKonstantin A. Artemenko
Konstantin A. Artemenko
LELioudmila Elfineh
Lioudmila Elfineh
YZYanhong Zhao
Yanhong Zhao
JBJonas Bergquist
Jonas Bergquist
UPUlf Pettersson
Ulf Pettersson